Drug Shortage Report for VENLAFAXINE XR

Last updated on 2023-10-01 History
Report ID 180268
Drug Identification Number 02516535
Brand name VENLAFAXINE XR
Common or Proper name Venlafaxine Hydrochloride Extended-Release Capsules
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 37.5MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 500
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-12-09
Estimated end date 2023-09-30
Actual end date 2023-09-30
Shortage status Resolved
Updated date 2023-10-01
Company comments Disruption of the manufacture of the drug. Other size available.
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2023-10-01 English Compare
v12 2023-09-26 French Compare
v11 2023-09-26 English Compare
v10 2023-09-26 French Compare
v9 2023-09-26 English Compare
v8 2023-08-03 French Compare
v7 2023-08-03 English Compare
v6 2023-05-05 French Compare
v5 2023-05-05 English Compare
v4 2023-02-03 French Compare
v3 2023-02-03 English Compare
v2 2023-01-09 French Compare
v1 2023-01-09 English Compare

Showing 1 to 13 of 13